Use of Artificial Intelligence in Improving Outcomes in Heart Disease
You are currently not logged in to PHD
To view this content, please login to your account, or within the login, click 'Create an Account' for guest access. To access AHA's full array of membership benefits, join or renew today!
Please note: AHA does not associate with, nor endorse YouTube recommendations.
In this video, Antonis Armoundas, PhD, principal investigator at Massachusetts General Hospital and Associate Professor of Medicine at Harvard Medical School and Jennifer Hall, PhD, FAHA, Chief of Data Science at the American Heart Association, discuss the recent scientific statement on the rapid growth of artificial intelligence (AI) in healthcare, the challenges in implementation, and best practices for use. The statement outlines a new framework for implementing artificial intelligence (AI) in cardiovascular disease monitoring and prevention.
Recommended Videos
Long-Term Reductions in Blood Pressure Renal Denervation for Resistant Hyp...
Recent Trials and Findings in Renal Denervation for Resistant Hypertension...
Addressing Hypertension Care for Uninsured and Underinsured Patients in a...
Addressing Non-English Speaking Patients in Team-based Hypertension Care i...
Key Statement Takeaways on Real-Life Implementation
Loading...
Save Video
Please note: AHA does not associate with, nor endorse YouTube recommendations.
Video is not available. Please check the URL.